Is Descovy really the better option?

When the FDA approved Gilead’s Truvada (emtricitabine/tenofovir disoproxil) for HIV PrEP in 2012, it was a revolutionary step forward. The drug was safe and up to 99 percent effective in preventing HIV infection in at-risk individuals. Then in 2019, Gilead received FDA approval for a second drug for PrEP called Descovy (emtricitabine/tenofovir alafenamide), with equivalentRead more …Is Descovy really the better option? originally appeared inKevinMD.com.

Source: Kevin, M.D. - Medical Weblog - December 12, 2021 Category: General Medicine Authors: < span itemprop="author" > < a href="https://www.kevinmd.com/blog/post-author/frank-f-zhou" rel="tag" > Frank F. Zhou < /a > < /span > Tags: Meds Infectious Disease Medications Source Type: blogs